IMCD

Rotterdam, Netherlands Founded: 1995 • Age: 31 yrs Listed Acquired By Abn Amro Fortune MNC 500 · #156
Speciality chemicals and food ingredients are distributed by IMCD.

About IMCD

IMCD is a publicly listed company based in Rotterdam (Netherlands) founded in 1995, and was acquired by Abn Amro in July 2005. Speciality chemicals and food ingredients are distributed by IMCD. The company has 5,130 employees. IMCD has completed 52 acquisitions, including ACM AB, Addpol Chemspecialities and Andes Chem. Its chief executive, as recorded, is Piet Slikke. Its website imcdgroup.com draws about 46 thousand monthly visits. Its Indian entity Imcd India Private Limited reported revenue of β‚Ή2,155 Cr. IMCD offers products and services including Specialty Chemicals and Ingredients. Its focus areas include Food and Agriculture, Food Distributors and Multi Category.

Company details

IMCD was established in 1995 in Rotterdam, Netherlands, as a distributor in the chemicals and food sectors. Operations are centered on sourcing and supplying speciality chemicals and ingredients to industries worldwide. Services include market expertise, technical support, and logistics management. The company is headquartered in Rotterdam, with a global network supporting clients in Europe, Asia, and the Americas. Leadership is provided by CEO Piet Slikke.

IMCD is ranked #156 on the Fortune MNC 500 India (2026).

Recognitions & Rankings of IMCD

Fortune MNC 500 India 2026 edition
Rank#156
Total income
₹4,626 Cr
Profit
₹267 Cr
Last year #226
  • Headquarters Rotterdam, Netherlands
  • Employees 5,130
  • Stage Public
  • Sectors
    Consumer
  • Website category Heavy Industry and Engineering · Chemical Industry
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website imcdgroup.com
  • Social LinkedIn X
  • Acquired by Abn Amro (Jul 2005)
  • Legal Name Imcd N.V.
Operational Areas
Key Metrics
  • Indian entity revenue
    ₹2,155 Cr

    FY 2025 · +17% YoY

  • Indian entity net profit
    ₹267 Cr

    FY 2025 · 6% margin

  • Indian entity EBITDA
    ₹657 Cr

    FY 2025 · 15% margin

  • Investors
  • Employee Count
    5,130
  • Investments & Acquisitions
    ACM AB

    & 51 more

  • Acquired by
    Abn Amro

    (Jul 2005)

Products & Services of IMCD

IMCD offers a comprehensive portfolio of products and services, including Specialty Chemicals and Ingredients.

Specialty Chemicals
Chemical Distribution

Specialty chemicals are distributed for use in industrial and manufacturing processes

Ingredients
Supply Services

Ingredients for food and pharmaceuticals are supplied through established networks

Funding Insights of IMCD

  • Total Rounds 2
  • First Round $94.87M

    (May 2015)

All 2 funding rounds of IMCD with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2020Post-IPO––
–
May 2015$94.87MPost-IPO––
–
Valuation history

1 investors in total: 1 institutional.

Investors in IMCD

IMCD has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include ABN AMRO.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
ABN AMRO is recognized as a personal bank in the digital era.
1991abnamro.comAmsterdam, Netherlands
Premium access

Investor details for IMCD

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Imcd India Private Limited (IMCD)

Imcd India Private Limited is the primary company behind IMCD. The board of Imcd India Private Limited currently have 2 directors; the longest-serving is Ramanuj Chandrashekhar Kankani, appointed in 2018. 7 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Ramanuj Chandrashekhar Kankani
DIN 08274950
Director04 Dec 20187 yrs 11 moImcd India Private Limited
Narendra Sujit Varde
DIN 09026419
Managing Director24 May 20233 yrs 5 moImcd India Private Limited

People of IMCD

57 people are tracked at IMCD (39 in leadership, 18 in team); the tracked headcount is 5,130.

NameRoleGroup
Piet Slikke
CEOLeadership
Daniela Bloomer
Head Of Marketing & Communications - Africa RegionLeadership
Artem Kryukov
Finance & Operations Director, DACH & SEELeadership
Nicky Huang
Managing Director IMCD China And IMCD SanriseLeadership
Valerie Diele-Braun
CEOLeadership
Hans Kooijmans
CFOLeadership
Marcus Jordan
COOLeadership
Arturo Hoyo
Managing DirectorLeadership
Managing DirectorLeadership
Jagdish Kuchibhatla
Business Development Director - Biopharmaceuticals, APACLeadership
Paul Hanbury
Managing Director IMCD UK | Director Home Care And I&i IMCD B.v.Leadership
Guido Smit
Group Supply Chain HeadLeadership
Leidy Guerrero
Finance & Operations DirectorLeadership
Stan Bijsterveld
Global Operations DirectorLeadership
Pimsiraya Vichaidit
Business Group Director Coating & Construction, APACLeadership
Alen Guy
Group Technical Excellence DirectorLeadership
Hugo Garcia
Business Director Food And NutritionLeadership
Natasha de Lange
Managing DirectorLeadership
Tosca Holtland
Head Of Investor RelationsLeadership
Eric Mitchell
Vice President Operations, USLeadership

37 more people are available in the full profile.

Premium access

Complete people profiles for IMCD

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of IMCD

IMCD is a publicly listed company on the EURONEXT with ticker symbol IMCD in Netherlands, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date27 Jun 2014
  • Listed onEuronext: IMCD
  • Listed entityIMCD N.V.
  • Exchange sectorProcess industries
  • ISINNL0010801007
  • Share price105.35 EUR (+2.03% on the day) · 2026-10-14
  • Market capitalisation6,093,606,297.00 EUR
  • Price to earnings27.0
  • EPS (diluted, trailing year)3.90 EUR
  • Dividend yield1.75%
  • Volume (last session)28,453

Financials of IMCD

Figures of Imcd India Private Limited, the primary company behind IMCD, for FY 2025. Revenue was ₹2,155 Cr (+17% year on year). Net profit was ₹267 Cr (6% margin). EBITDA was ₹657 Cr (15% margin). Revenue has grown at a compounded annual rate of +25% over three years and +50% over five years.

  • ₹2,155 CrRevenue · FY 2025 · +17% YoY
  • ₹267 CrNet profit · 6% margin
  • ₹657 CrEBITDA · 15% margin
  • ₹79.26 CrPaid-up capital
  • 262Employees (provident fund records)
  • +25%Revenue CAGR, 3 years
  • +50%Revenue CAGR, 5 years
Exchange-reported annual figures
YearRevenueNet incomeEBITDA
20254.78B EUR217.6M EUR507.5M EUR
20244.73B EUR278.2M EUR553.3M EUR
20234.44B EUR292.3M EUR526.4M EUR
20224.60B EUR313.1M EUR562.3M EUR
20213.44B EUR207.3M EUR385.4M EUR

Balance sheet, profit and loss, cash flow and ratios of Imcd India Private Limited are on its company page.

Premium access

Detailed financial statements for IMCD

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by IMCD

IMCD has strategically engaged in corporate development activities, having acquired 52 companies. Notable acquisitions include ACM AB, Addpol Chemspecialities and Andes Chem.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Specialty chemicals and intermediates are supplied to pharmaceutical manufacturers.
tricheminc.netMumbai, India1998Jun 2025β€’β€’β€’β€’
Food ingredients are sourced and distributed to producers worldwide.
ferreralimentacion.com0Jun 2025β€’β€’β€’β€’
Food and nutraceutical ingredients are supplied to the food industry.
tecom.esSpain1996May 2025β€’β€’β€’β€’
Ingredient solutions for food, pharmaceuticals, and industries are supplied.
blumos.clChile1947Oct 2024β€’β€’β€’β€’
API manufacturing is specialized in by Selechimica as a CDMO.
0Jun 2024β€’β€’β€’β€’
Manufacturing of pharmaceutical products is conducted by COBAPHARMA.
cobapharma.comBarcelona, Spain2011Apr 2024β€’β€’β€’β€’
Cosmetics and personal care ingredients are distributed in Benelux.
gova-benelux.comHoogerheide, Netherlands1999Mar 2024β€’β€’β€’β€’
Provider of animal nutrition, refrigerants, industrial, and food products supplying services
bretano.comHeredia, Costa Rica1961Mar 2024β€’β€’β€’β€’
Company specializes in resins, additives, and pigments for use in inks, coatings, adhesives, and the construction industry
reschemtechnologies.comSydney, Australia2007Feb 2024β€’β€’β€’β€’
Cosmetic, food, and industrial chemicals are distributed across South Asia.
valuetree.inMumbai, India2006Jan 2024β€’β€’β€’β€’
Premium access

Complete acquisition details for IMCD

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of IMCD

15 dated milestones of IMCD across 30 years, from founding to its latest funding, stage changes and deals.

  1. Founded IMCD is founded.
  2. Exit Acquired by Abn Amro.
  3. IPO Lists on the stock exchange (IPO).
  4. Funding First funding round of $94.9M.
  5. Funding Latest funding round, Post-IPO,.
  6. Acquisition Acquires ValueTree.
  7. Acquisition Acquires ResChem.
  8. Acquisition Acquires Bretano.
  9. Acquisition Acquires GOVA INGREDIENTS.
  10. Acquisition Acquires COBAPHARMA.
  11. Acquisition Acquires Selechimica.
  12. Acquisition Acquires Blumos.
  13. Acquisition Acquires Tecom Ingredients.
  14. Acquisition Acquires Ferreralimentacion.
  15. Acquisition Acquires Trichem Pharmascience.

Web traffic of IMCD

The website of IMCD (imcdgroup.com) receives about 46.1K visits a month and ranks #636,088 among all websites worldwide, #9,598 in Chemical Industry.

  • Monthly visits
    46.1K

    ▼ 12% vs previous month

  • Unique visitors
    20.9K

    per month

  • Global rank
    #636,088

    among all websites

  • Category rank
    #9,598

    Heavy Industry and Engineering · Chemical Industry

Similar websites

Websites whose visitors overlap most with IMCD. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
azelis.com
100%
89.9K#436,305View details
caldic.com
99%
88.5K#425,565View details
thirumalaichemicals.com
82%
2.9K#5,643,260View details
calibrechem.com
80%
4.9K#3,930,362View details
makwater.com.au
42%
5.3K#3,720,843View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 7 similar websites and full traffic analytics for IMCD

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 7 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Imcd

Premium access

Complete news archive for IMCD

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about IMCD

IMCD was founded in 1995 and raised its 1st funding round 20 years after it was founded.

IMCD is headquartered in Rotterdam, Netherlands. It is registered at Rotterdam, South Holland, Netherlands.

Piet Slikke is the CEO of IMCD, as recorded in our data.

IMCD has 5,130 employees.

The primary company behind IMCD, Imcd India Private Limited, reported revenue of β‚Ή2,155 Cr for FY 2025, up 17% year on year.

IMCD was established in 1995 in Rotterdam, Netherlands, as a distributor in the chemicals and food sectors. Operations are centered on sourcing and supplying speciality chemicals and ingredients to industries worldwide. Services include market expertise, technical support, and logistics management. The company is headquartered in Rotterdam, with a global network supporting clients in Europe, Asia, and the Americas. Leadership is provided by CEO Piet Slikke.

IMCD offers Specialty Chemicals and Ingredients.

Yes, IMCD is publicly traded on EURONEXT under the ticker symbol IMCD.

IMCD has made 52 acquisitions, including ACM AB, Addpol Chemspecialities, and Andes Chem.

IMCD has 1 investor. Key investors include ABN AMRO.

IMCD operates through Imcd India Private Limited.

Yes. IMCD was acquired by Abn Amro in July 2005.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available